These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29407284)

  • 1. Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
    Bogaty SER; Lee RSC; Hickie IB; Hermens DF
    J Psychiatr Res; 2018 Apr; 99():22-32. PubMed ID: 29407284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropsychological profiles of young psychosis patients with and without current cannabis use.
    Bogaty SER; Crouse JJ; Hickie IB; Hermens DF
    Cogn Neuropsychiatry; 2019 Jan; 24(1):40-53. PubMed ID: 30621505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
    Metzler S; Dvorsky D; Wyss C; Nordt C; Walitza S; Heekeren K; Rössler W; Theodoridou A
    Psychiatry Res; 2016 Dec; 246():188-194. PubMed ID: 27718468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis.
    Buck G; Lavigne KM; Makowski C; Joober R; Malla A; Lepage M
    Schizophr Bull; 2020 Dec; 46(6):1587-1595. PubMed ID: 32307536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts.
    Kennedy L; Ku BS; Addington J; Amir CM; Bearden CE; Cannon TD; Carrión R; Cornblatt B; Keshavan M; Perkins D; Mathalon D; Stone W; Walker E; Woods S; Cadenhead KS
    Schizophr Res; 2024 Sep; 271():319-331. PubMed ID: 39084107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis users have higher premorbid IQ than other patients with first onset psychosis.
    Ferraro L; Russo M; O'Connor J; Wiffen BD; Falcone MA; Sideli L; Gardner-Sood P; Stilo S; Trotta A; Dazzan P; Mondelli V; Taylor H; Friedman B; Sallis H; La Cascia C; La Barbera D; David AS; Reichenberg A; Murray RM; Di Forti M
    Schizophr Res; 2013 Oct; 150(1):129-35. PubMed ID: 23958486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.
    Ayesa-Arriola R; Rodríguez-Sánchez JM; Suero ES; Reeves LE; Tabarés-Seisdedos R; Crespo-Facorro B
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):619-28. PubMed ID: 26769121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
    Stefanatou P; Karatosidi CS; Tsompanaki E; Kattoulas E; Stefanis NC; Smyrnis N
    Psychiatry Res; 2018 Sep; 267():249-255. PubMed ID: 29940456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study.
    Tervo-Clemmens B; Simmonds D; Calabro FJ; Montez DF; Lekht JA; Day NL; Richardson GA; Luna B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Aug; 3(8):713-725. PubMed ID: 30033100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cannabis affect cognitive functioning in patients with schizophrenia?
    Rachid H; Saif Z; Raoui S; Serhier Z; Agoub M
    Schizophr Res Cogn; 2024 Jun; 36():100299. PubMed ID: 38196922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.
    Allott K; Fraguas D; Bartholomeusz CF; Díaz-Caneja CM; Wannan C; Parrish EM; Amminger GP; Pantelis C; Arango C; McGorry PD; Rapado-Castro M
    Psychol Med; 2018 Jul; 48(10):1592-1607. PubMed ID: 29173201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metacognition strengthens the association between neurocognition and attenuated psychosis syndrome: Preliminary evidence from a pilot study among treatment-seeking versus healthy adolescents.
    Koren D; Scheyer R; Stern Y; Adres M; Reznik N; Apter A; Seidman LJ
    Schizophr Res; 2019 Aug; 210():207-214. PubMed ID: 30630704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of childhood/adolescent and adult onset schizophrenia: does the neurocognitive and psychosocial outcome differ?
    Grover S; Sahoo S; Nehra R
    Asian J Psychiatr; 2019 Jun; 43():160-169. PubMed ID: 31176081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use.
    Hanna RC; Shalvoy A; Cullum CM; Ivleva EI; Keshavan M; Pearlson G; Hill SK; Sweeney JA; Tamminga CA; Ghose S
    Schizophr Bull; 2016 Nov; 42(6):1496-1503. PubMed ID: 27033329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.